HRN-65987-99426
2 vaccinations
1 coded response
16 check-ins
0 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 200 / DC
- Registered
- 2022-06-25
- Relationship
- Child or adolescent in my care
- Guardian
- YQK-12941-42703
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-25
Registered in v-safe
-
2022-06-25
Dose 1 — Pfizer-BioNTech
- 2022-06-26
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-04
- 2022-07-09
-
2022-07-16
Dose 2 — Pfizer-BioNTech
- 2022-07-16
- 2022-07-17
- 2022-07-19
- 2022-07-20
- 2022-07-21
- 2022-07-22
- 2022-07-30
- 2022-08-08
- 2022-10-16
-
2023-01-14
Survey response — 6 months, dose 2, under 3MedDRA: Cough, Pyrexia, Rash, Rhinorrhoea — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-14
Report sent to call center — 6 months, dose 2, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-25 | Pfizer-BioNTech | No |
| 2 | 2022-07-16 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-01-14 | Unsuccessful |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release